Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself
Clinical trial NCT00457678 · WITHDRAWN
Trial details
- NCT number
- NCT00457678
- Sponsor
- Vitreous -Retina- Macula Consultants of New York
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2007-12-04
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.